BlackRock Investment Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-8
| Closed | -$2K | – | 4040 |
|
2016
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 3947 |
|
2015
Q4 | $3K | Hold |
8
| – | – | ﹤0.01% | 3938 |
|
2015
Q3 | $4K | Buy |
8
+2
| +33% | +$1K | ﹤0.01% | 3968 |
|
2015
Q2 | $13K | Sell |
6
-1
| -14% | -$2.17K | ﹤0.01% | 3591 |
|
2015
Q1 | $17K | Hold |
7
| – | – | ﹤0.01% | 3466 |
|
2014
Q4 | $15K | Hold |
7
| – | – | ﹤0.01% | 3522 |
|
2014
Q3 | $14K | Hold |
7
| – | – | ﹤0.01% | 3517 |
|
2014
Q2 | $25K | Sell |
7
-116
| -94% | -$414K | ﹤0.01% | 3333 |
|
2014
Q1 | $461K | Buy |
123
+1
| +0.8% | +$3.75K | ﹤0.01% | 2976 |
|
2013
Q4 | $399K | Sell |
122
-2
| -2% | -$6.54K | ﹤0.01% | 3040 |
|
2013
Q3 | $521K | Hold |
124
| – | – | ﹤0.01% | 2895 |
|
2013
Q2 | $417K | Buy |
+124
| New | +$417K | ﹤0.01% | 2946 |
|